STIM-R SYNTHETIC T CELL IMMUNE MICROENVIRONMENT-REPROGRAMMING

Published

Owner Info

Lyell Immunopharma

Lyell Immunopharma, Inc., a corporation organised and existing under the laws of the State of Delaware, 201 Haskins Way, South San Francisco, California, 94080, United States of America.

Serial Number

2022-00935 filed on 12 Jan 2022

Correspondent

SPOOR & FISHER

SPOOR & FISHER, Messrs. Spoor & Fisher, 11 Byls Bridge Boulevard, Building No. 14, Highveld Ext 73, Centurion, Pretoria, 0157,

STIM-R SYNTHETIC T CELL IMMUNE MICROENVIRONMENT-REPROGRAMMING

Classification Information

Class [044]
Medical, pharmaceutical and biotechnological research; medical services.

Mark Details

Serial Number

2022-00935

Owner Name

Lyell Immunopharma

Filed On

12 Jan 2022

Law Firm

SPOOR & FISHER

Correspondent

Law Firm Name

SPOOR & FISHER

Address

SPOOR & FISHER, Messrs. Spoor & Fisher, 11 Byls Bridge Boulevard, Building No. 14, Highveld Ext 73, Centurion, Pretoria, 0157

STIM-R SYNTHETIC T CELL IMMUNE MICROENVIRONMENT-REPROGRAMMING

Classification Information

Class [044]Medical, pharmaceutical and biotechnological research; medical services.

Mark Details

Serial Number

Owner Name

Filed On

Law Firm

Correspondent

Law Firm Name

Address

Class [044]
Medical, pharmaceutical and biotechnological research; medical services.